GINGER HAMILTON: Open Payments
NPI 1063957843 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 38 payments from 13 companies in 2025. Trend: 2023 $782 · 2024 $682 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $174 |
| Amgen Inc. | 5 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| Novo Nordisk Inc | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Exact Sciences Corporation | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
Products named: VRAYLAR, JARDIANCE, OTEZLA, TRELEGY ELLIPTA, AIRSUPRA, Cologuard Collection Kit, FARXIGA, REPATHA.
Industry payments across IA — which companies pay providers there.
